2025
SJR Q3
JCR Q4 · 0,6
OA
5 matched articles
ESCI
Journal detail
HIV and AIDS Review
- Publisher
- Termedia Publishing House Ltd.
- Country
- Poland · Eastern Europe
- Type
- journal
- ISSN
-
1730127017322707
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,322
- Quartile Q3
- H-Index 11
- Cites/doc 0,59
- Docs (3y) 148
- Cites (3y) 105
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,6
- 5Y JIF 0,5
- JCI 0,12
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Epidemiology Q3
- Infectious Diseases Q3
Areas
- Medicine
WoS categories
- Infectious Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,322 | 0,6 | 0,5 | 0,12 | Q4 | 11 |
| 2024 | Q4 | Q4 | 0,175 | 0,3 | 0,3 | 0,06 | Q4 | 10 |
| 2023 | Q4 | Q4 | 0,159 | 0,3 | 0,3 | 0,05 | Q4 | 10 |
| 2022 | Q4 | — | 0,151 | 0,2 | 0,2 | 0,04 | Q4 | 10 |
| 2021 | Q4 | — | 0,151 | — | — | 0,06 | Q4 | 10 |
| 2020 | Q4 | — | 0,156 | — | — | 0,05 | Q4 | 10 |
| 2019 | Q4 | — | 0,184 | — | — | — | — | 10 |
| 2017 | Q4 | — | 0,134 | — | — | — | — | 10 |
| 2016 | Q4 | — | 0,156 | — | — | — | — | 10 |
| 2015 | Q4 | — | 0,177 | — | — | — | — | 10 |
| 2014 | Q4 | — | 0,134 | — | — | — | — | 10 |
| 2013 | Q4 | — | 0,123 | — | — | — | — | 10 |
| 2012 | Q4 | — | 0,13 | — | — | — | — | 10 |
| 2011 | Q4 | — | 0,102 | — | — | — | — | 10 |
| 2010 | Q4 | — | 0,1 | — | — | — | — | 10 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | INFECTIOUS DISEASES | ESCI | Q4 | Q4 | 132/141 |
| 2024 | INFECTIOUS DISEASES | ESCI | Q4 | Q4 | 129/137 |
| 2023 | INFECTIOUS DISEASES | ESCI | Q4 | Q4 | 126/132 |
| 2022 | INFECTIOUS DISEASES | ESCI | — | Q4 | — |
| 2021 | INFECTIOUS DISEASES | ESCI | — | Q4 | — |
| 2020 | INFECTIOUS DISEASES | ESCI | — | Q4 | — |